[Visceral mycotic infections. In clinical practice].
André
M H
MH
Lortholary
O
O
D000666:Amphotericin B / Q000627:therapeutic use; D000935:Antifungal Agents / Q000627:therapeutic use; D002177:Candidiasis / Q000175:diagnosis / Q000628:therapy; D003453:Cryptococcosis / Q000175:diagnosis / Q000628:therapy; D015725:Fluconazole / Q000627:therapeutic use; D005437:Flucytosine / Q000627:therapeutic use; D006660:Histoplasmosis / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D009172:Mycology / Q000379:methods; D009181:Mycoses / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy; D009503:Neutropenia / Q000150:complications; D011379:Prognosis; D012307:Risk Factors; D014195:Travel
D000935:Antifungal Agents; D000666:Amphotericin B; D015725:Fluconazole; D005437:Flucytosine